PubMed:23592772 / 0-172 JSONTXT

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":109},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":110,"end":116},"obj":"HP_0002664"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"23592772-0#67#72#gene4790","span":{"begin":67,"end":72},"obj":"gene4790"},{"id":"23592772-0#67#72#gene4790","span":{"begin":67,"end":72},"obj":"gene4790"},{"id":"23592772-0#85#102#diseaseC0235974","span":{"begin":85,"end":102},"obj":"diseaseC0235974"},{"id":"23592772-0#85#102#diseaseC0346647","span":{"begin":85,"end":102},"obj":"diseaseC0346647"},{"id":"23592772-0#0#5#diseaseC0424295","span":{"begin":0,"end":5},"obj":"diseaseC0424295"}],"relations":[{"id":"67#72#gene479085#102#diseaseC0235974","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#85#102#diseaseC0235974"},{"id":"67#72#gene479085#102#diseaseC0346647","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#85#102#diseaseC0346647"},{"id":"67#72#gene47900#5#diseaseC0424295","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#0#5#diseaseC0424295"},{"id":"67#72#gene479085#102#diseaseC0235974","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#85#102#diseaseC0235974"},{"id":"67#72#gene479085#102#diseaseC0346647","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#85#102#diseaseC0346647"},{"id":"67#72#gene47900#5#diseaseC0424295","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#0#5#diseaseC0424295"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":85,"end":102},"obj":"Disease"},{"id":"T3","span":{"begin":110,"end":116},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005192"},{"id":"A2","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009831"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":85,"end":102},"obj":"Phenotype"},{"id":"T2","span":{"begin":110,"end":116},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002894"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":85,"end":102},"obj":"Disease"},{"id":"T3","span":{"begin":110,"end":116},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005192"},{"id":"A2","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009831"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"GlyCosmos15-CL","denotations":[{"id":"T1","span":{"begin":96,"end":108},"obj":"Cell"},{"id":"T2","span":{"begin":110,"end":121},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0001064"},{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0001064"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":109},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":109},"obj":"Sentence"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":85,"end":102},"obj":"Phenotype"},{"id":"T2","span":{"begin":110,"end":116},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002894"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}

{"project":"CL-cell","denotations":[{"id":"T1","span":{"begin":96,"end":108},"obj":"Cell"},{"id":"T2","span":{"begin":110,"end":121},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0001064"},{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0001064"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCancer cell metabolic reprogramming includes a shift in energy"}